Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target

Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target

ObjectivesTo investigate the association of anti-citrullinated protein antibodies (ACPA) with changes in systemic bone mineral density (BMD) in patients with early rheumatoid arthritis (RA) after two years of treat-to-target.MethodsBMD was measured at the lumbar spine (LS) and femoral neck (FN) in 1...

Full description

Bibliographic Details
Main Authors: Serena Bugatti, Laura Bogliolo, Antonio Manzo, Ludovico De Stefano, Paolo Delvino, Francesca Motta, Carlomaurizio Montecucco
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
anti-citrullinated protein autoantibodies
bone mineral density
osteoporosis 3
rheumatoid factor
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.701922/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.701922/full

Similar Items